Supporting More Patients and Sites to Participate in Clinical Trials Remotely while Demonstrating Tangible ROI
The Mobile in Clinical Trials® conference focused on the successful implementation of mobile technologies in clinical trials, emphasizing positive experiencs for both patients and sites. The event examined how mobile and digital technologies have been effectively utilized in clinical trials, addressing one of the largest challenges to date: demonstrating ROI.
R&D, operations, digital leaders, and patient engagement executives shared their insights and strategies for supporting more patients remotely while managing valuable data and ensuring comprehensive patient and site support.
What Attendees Walked Away With:
• Cutting-edge insights on using mobile and digital technologies for clinical trials to stay ahead of industry trends and innovations.
• Tools and knowledge to effectively demonstrate ROI, showcasing the tangible benefits of mobile and digital solutions in clinical trials.
• Firsthand insights from patients and clinical sites on the utilization of mobile technology to enhance trial outcomes and patient experiences.
• Valuable networking opportunities with industry stakeholders to share insights and best practices, enhancing your professional practices within the field.
• Actionable strategies for optimizing trial efficiency and driving better outcomes, and practical solutions to common implementation challenges.
2024 Co-Chairs
Adama Ibrahim, MBA
Novo Nordisk
Kai Bode
Merck
Mackenzie Abramson, MPH
Patient Advocate
How to Adopt, Deploy and Scale Tech for Patient Benefit. What's Working, What's Not.
2024 Topics Covered:
- What to Expect from the Mobile Health Tech Landscape
- AI in Mobile Technologies and What’s Next for Clinical Trials
- Patient and Site Preferences for Digital Technologies in Clinical Trials
- Tailoring Digital Implementation for Patient-Centric Trials
- Adopting New Novel Endpoints and Digital Biomarkers via Wearable Devices
- How Mobile Technologies are Working for Pediatric Trials
- Case Studies on the Implementation of Mobile Technologies
- Demonstrating the Value and ROI of Digital Health Technologies (DHTs) in Trials
- Addressing Globalization Challenges with DHT Implementation
- FDA Guidance Updates and New Agency Initiatives on DHTs in Clinical Trials
- And More
Why Mobile in Clinical Trials
is Important for the Industry
A message from 2024 Co-Chair, Adama Ibrahim,
Novo Nordisk.
2024 Sponsors Included:
.png)
.png)
.png)
